386(top 1%)
papers
9.4K(top 1%)
citations
46(top 1%)
h-index
83(top 1%)
g-index
421
all documents
10.2K
doc citations
1.9K
citing journals

Top Articles

#TitleJournalYearCitations
1The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of InflammationEuropean Urology2011351
2EAU Guidelines on Urinary IncontinenceEuropean Urology2011310
3The Correlation Between Metabolic Syndrome and Prostatic DiseasesEuropean Urology2012297
4Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?European Urology2016282
5EAU Guidelines on Assessment and Nonsurgical Management of Urinary IncontinenceEuropean Urology2018237
6A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysisEuropean Urology2012231
7Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate CancerEuropean Urology2011225
8A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH StudyEuropean Urology2016201
9Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized studyUrologic Oncology: Seminars and Original Investigations2015197
10Urology practice during the COVID-19 pandemicMinerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology2020195
11180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial—The GOLIATH StudyEuropean Urology2014189
12Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysisBJU International2015189
13Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature ReviewEuropean Urology2009174
14Inflammation and Chronic Prostatic Diseases: Evidence for a Link?European Urology2007159
15Defining overactive bladder: Epidemiology and burden of diseaseUrology2004156
16Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?European Urology2020150
17Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and preventionVirology Journal2009147
18Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort StudyEuropean Urology2015147
19Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?European Urology2018141
20Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imagingEuropean Radiology2013132
21A European Multicenter Randomized Noninferiority Trial Comparing 180 W GreenLight XPS Laser Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 12-Month Results of the GOLIATH StudyJournal of Urology2015117
22Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaProstate199895
23Ultrasound Assessment of Intravesical Prostatic Protrusion and Detrusor Wall Thickness—New Standards for Noninvasive Bladder Outlet Obstruction Diagnosis?Journal of Urology201094
24Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the randomized, double‐blind Combination of Avodart and Tamsulosin (CombAT) trialBJU International201192
25Clinical pathways for urology patients during the COVID-19 pandemicMinerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology202080
26An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerWorld Journal of Urology201977
27Love at the time of the Covid-19 pandemic: preliminary results of an online survey conducted during the quarantine in ItalyInternational Journal of Impotence Research202076
28Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective StudyCancers201973
29Expression and Cellular Localization of Follicle-Stimulating Hormone Receptor in Normal Human Prostate, Benign Prostatic Hyperplasia and Prostate CancerJournal of Urology200670
30Nitric oxide synthases in normal and benign hyperplastic human prostate: Immunohistochemistry and molecular biology199969
31Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancerArchivio Italiano Di Urologia Andrologia201969
32Urothelial Bladder Carcinoma and Viral Infections: Different Association with Human Polyomaviruses and Papilloma VirusesInternational Journal of Immunopathology and Pharmacology200366
33Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder CancerEuropean Urology Oncology201866
34Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future PerspectivesDiagnostics202164
35Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?BMC Urology201563
36Radiomics in prostate cancer: an up-to-date reviewTherapeutic Advances in Urology202262
37Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder CancerJournal of Personalized Medicine202158
38Use of Terazosin in the Medical Treatment of Benign Prostatic Hyperplasia: Experience in ItalyBritish Journal of Urology199257
39Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder CancerClinical Genitourinary Cancer201855
40Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients’ quality of lifeEuropean Journal of Neurology201654
41Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillanceOncotarget201752
42Diagnostic value of qualitative and strain ratio elastography in the differential diagnosis of non‐palpable testicular lesionsAndrology201651
43Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA databaseEuropean Journal of Surgical Oncology201651
44ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Psychosocial Outcomes and Drug Attributes Affecting Treatment Choice in Men Receiving Sildenafil Citrate and Tadalafil for the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Open‐Label, Crossover StudyJournal of Sexual Medicine200650
45Up‐regulation of the inflammatory‐reparative phenotype in human prostate carcinomaProstate200950
46Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort studyUrologic Oncology: Seminars and Original Investigations201350
47Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumorWorld Journal of Urology202049
48Bipolar Transurethral Resection of Prostate: Clinical and Urodynamic EvaluationUrology200848
49Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pHJournal of Enzyme Inhibition and Medicinal Chemistry202047
50Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4‐year results of the CombAT studyBJU International201446